Short Bowel Syndrome Market to Reach USD 4.1 Billion by 2035, Driven by Advances in Treatment
Market Overview According to MarketGenics, the market is valued at USD 1.6 billion in 2025 and is projected to reach USD 4.1 billion by 2035, registering a CAGR of 9.8% during the forecast period. The global Short Bowel Syndrome (SBS) market is driven by the growing need for effective treatments for patients who experience inadequate nutrient absorption due to significant loss or dysfunction of the small intestine. Short bowel syndrome is a rare, chronic condition that can result from intestinal resection, congenital abnormalities, or intestinal diseases, often requiring long-term nutritional support and specialized medical care. The market includes pharmaceutical therapies, parenteral nutrition, enteral nutrition, and supportive treatments designed to improve intestinal absorption and reduce dependence on intravenous nutritional support. Advances in gastrointestinal medicine and the development of therapies that promote intestinal adaptation are creating new opportunities f...